MedTrace Logo

Serum Amyloid A Protein And Fetuin A Levels

NCT02433405 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2015-05-05

No results posted yet for this study

Summary

The purpose of this study was to evaluate acute phase proteins (APPs) Fetuin-A and Serum Amyloid A (SAA) levels in gingival crevicular fluid (GCF) and serum samples in periodontal health and disease.

Conditions

  • Periodontal Diseases

Interventions

BIOLOGICAL

Fetuin-A

Acute phase protein

BIOLOGICAL

Serum Amyloid A

Acute phase protein

Sponsors & Collaborators

  • Bulent Ecevit University

    lead OTHER

Principal Investigators

  • ÇİĞDEM COŞKUN TÜRER, PhD · BULENT ECEVIT UNIVERSITY FACULTY OF DENTISTRY DEPARTMENT OF PERIODONTOLOGY

Eligibility

Min Age
28 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-04-30
Completion
2014-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02433405 on ClinicalTrials.gov